1 completed, 1 not yet recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Imaging: new trials by email Literature Review of Imaging trials Research Report on Imaging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors. LNTH-2403 - Imaging, Colorectal Cancer | Phase 1 | Not yet recruiting | Radiopharm Theranostics, Ltd | 16 | 2026-10-30 | 2026-08-12 |
| Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery Bevonescein - Parotid Neoplasm, Thyroid Neoplasms | Phase 1 / Phase 2 | Completed | Alume Biosciences, Inc. | 27 | 2020-06-18 | 2025-05-08 |
Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Head and Neck Neoplasms (1) · Parotid Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Thyroid Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Neoplasms (2) · Neoplasms by Site (2) · Breast Diseases (1) · Breast Neoplasms (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Squamous Cell (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1)
Alume Biosciences, Inc. (1) · Radiopharm Theranostics, Ltd (1)
Australia (1) · United States (1)